Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Timmermans

Showing results (91-100 of 292) with videos related to

Pageof 30
Sort By:
Journal De Pharmacologie|July 1, 1982
[Interaction between calcium antagonists and vascular postsynaptic alpha-receptors]J C van Meel, P B Timmermans, P A van Zwieten
European Heart Journal|May 1, 1983
Calcium antagonists and alpha-receptorsP B Timmermans, J C van Meel, P A van Zwieten
American Journal of Hypertension|April 1, 1991
DuP 753 is a potent nonpeptide antagonist of angiotensin II receptors in isolated perfused rat kidney and cultured renal cellsB M Fontoura, D R Nussenzveig, P B Timmermans, et al.
Circulation Research|February 1, 1983
Functional interaction between calcium antagonists and the vasoconstriction induced by the stimulation of postsynaptic alpha 2-adrenoceptorsP A van Zwieten, J C van Meel, P B Timmermans
Pharmaceutisch Weekblad. Scientific Edition|December 18, 1981
Vascular aspects of calcium antagonistsP A Van Zwieten, J C Van Meel, P B Timmermans
Hypertension (Dallas, Tex. : 1979)|July 1, 1983
Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptorsP A van Zwieten, J C van Meel, P B Timmermans
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
The preclinical basis of the therapeutic evaluation of losartanP B Timmermans, P C Wong, A T Chiu, et al.
American Journal of Hypertension|April 1, 1991
Effects of the nonpeptide angiotensin II receptor antagonist DuP 753 on blood pressure and renal functions in spontaneously hypertensive PH dogsK C Bovee, P C Wong, P B Timmermans, et al.
Proceedings of the Western Pharmacology Society|January 1, 1992
Novel non-peptide angiotensin II receptor antagonistsP B Timmermans, A T Chiu, R D Smith, et al.
Thrombosis and Haemostasis|January 23, 1992
In vivo characterization of a new synthetic thrombin inhibitorR M Knabb, C A Kettner, P B Timmermans, et al.
Pageof 30

Showing results (91-100 of 292) with videos related to

Sort By:
Pageof 30
Journal De Pharmacologie|July 1, 1982
[Interaction between calcium antagonists and vascular postsynaptic alpha-receptors]J C van Meel, P B Timmermans, P A van Zwieten
European Heart Journal|May 1, 1983
Calcium antagonists and alpha-receptorsP B Timmermans, J C van Meel, P A van Zwieten
American Journal of Hypertension|April 1, 1991
DuP 753 is a potent nonpeptide antagonist of angiotensin II receptors in isolated perfused rat kidney and cultured renal cellsB M Fontoura, D R Nussenzveig, P B Timmermans, et al.
Circulation Research|February 1, 1983
Functional interaction between calcium antagonists and the vasoconstriction induced by the stimulation of postsynaptic alpha 2-adrenoceptorsP A van Zwieten, J C van Meel, P B Timmermans
Pharmaceutisch Weekblad. Scientific Edition|December 18, 1981
Vascular aspects of calcium antagonistsP A Van Zwieten, J C Van Meel, P B Timmermans
Hypertension (Dallas, Tex. : 1979)|July 1, 1983
Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptorsP A van Zwieten, J C van Meel, P B Timmermans
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
The preclinical basis of the therapeutic evaluation of losartanP B Timmermans, P C Wong, A T Chiu, et al.
American Journal of Hypertension|April 1, 1991
Effects of the nonpeptide angiotensin II receptor antagonist DuP 753 on blood pressure and renal functions in spontaneously hypertensive PH dogsK C Bovee, P C Wong, P B Timmermans, et al.
Proceedings of the Western Pharmacology Society|January 1, 1992
Novel non-peptide angiotensin II receptor antagonistsP B Timmermans, A T Chiu, R D Smith, et al.
Thrombosis and Haemostasis|January 23, 1992
In vivo characterization of a new synthetic thrombin inhibitorR M Knabb, C A Kettner, P B Timmermans, et al.
Pageof 30